Advertisement
Advertisement

AXSM

AXSM logo

Axsome Therapeutics, Inc

178.69
USD
Sponsored
-4.05
-2.22%
Jan 02, 15:59 UTC -5
Closed
exchange

Pre-Market

177.79

-0.90
-0.50%

AXSM Earnings Reports

Positive Surprise Ratio

AXSM beat 20 of 40 last estimates.

50%

Next Report

Date of Next Report
Feb 16, 2026
Estimate for Q4 25 (Revenue/ EPS)
$191.46M
/
-$0.47
Implied change from Q3 25 (Revenue/ EPS)
+11.97%
/
-50.00%
Implied change from Q4 24 (Revenue/ EPS)
+61.21%
/
-69.48%

Axsome Therapeutics, Inc earnings per share and revenue

On Nov 03, 2025, AXSM reported earnings of -0.94 USD per share (EPS) for Q3 25, missing the estimate of -0.88 USD, resulting in a -6.47% surprise. Revenue reached 170.99 million, compared to an expected 165.80 million, with a 3.13% difference. The market reacted with a +0.56% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 22 analysts forecast an EPS of -0.47 USD, with revenue projected to reach 191.46 million USD, implying an decrease of -50.00% EPS, and increase of 11.97% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Holdings Inc. Common Stock
Report Date
Dec 22, 2025 For Q4 25
Estimate
-$0.57
Actual
-$0.73
Surprise
-25.95%
logo
Citius Oncology, Inc. Common Stock
Report Date
Dec 23, 2025 For Q4 25
Estimate
-$0.12
Actual
-$0.06
Surprise
+50.98%
FAQ
For Q3 2025, Axsome Therapeutics, Inc reported EPS of -$0.94, missing estimates by -6.47%, and revenue of $170.99M, 3.13% above expectations.
The stock price moved up 0.56%, changed from $134.99 before the earnings release to $135.75 the day after.
The next earning report is scheduled for Feb 16, 2026.
Based on 22 analysts, Axsome Therapeutics, Inc is expected to report EPS of -$0.47 and revenue of $191.46M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement